Interaction of fluorescein derivatives with glibenclamide binding sites in rat brain

[1]  M. Lazdunski,et al.  K+ channel openers prevent global ischemia-induced expression of c-fos, c-jun, heat shock protein, and amyloid beta-protein precursor genes and neuronal death in rat hippocampus. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[2]  M. Roisin,et al.  Effect of potassium channel modulators on the release of glutamate induced by ischaemic-like conditions in rat hippocampal slices , 1993, Neuroscience Letters.

[3]  Y. Ben-Ari,et al.  Nucleotides modulate the low affinity binding sites for [3H]glibenclamide in the rat brain. , 1993, The Journal of pharmacology and experimental therapeutics.

[4]  F. Ashcroft,et al.  The sulfonylurea receptor. , 1992, Biochimica et biophysica acta.

[5]  M. Lazdunski,et al.  ATP/ADP binding sites are present in the sulfonylurea binding protein associated with brain ATP-sensitive K+ channels. , 1992, Biochemistry.

[6]  M. Lazdunski,et al.  Activation and inhibition of ATP-sensitive K+ channels by fluorescein derivatives. , 1992, The Journal of biological chemistry.

[7]  J. Mark Treherne,et al.  The regional distribution of sulphonylurea binding sites in rat brain , 1991, Neuroscience.

[8]  D. Triggle,et al.  Characterization of binding of the ATP-sensitive potassium channel ligand, [3H]glyburide, to neuronal and muscle preparations. , 1991, The Journal of pharmacology and experimental therapeutics.

[9]  Y. Ben-Ari,et al.  Two binding sites for [3H]glibenclamide in the rat brain , 1991, Brain Research.

[10]  M. Lazdunski,et al.  Specific hippocampal lesions indicate the presence of sulfonylurea binding sites associated to ATP-sensitive K+ channels both post-synaptically and on mossy fibers , 1991, Brain Research.

[11]  Y. Ben-Ari,et al.  Activators of ATP-sensitive K+ channels reduce anoxic depolarization in CA3 hippocampal neurons , 1990, Neuroscience.

[12]  N. S. Cook,et al.  Potassium Channels — Structure, Classification, Function and Therapeutic Potential Nigel S. Cook (ed.) Ellis Horwood, 1990. £59.95 (412 pages) ISBN 0 7458 0624 4 , 1990, Trends in Neurosciences.

[13]  M. Lazdunski,et al.  Brain ischemia alters the density of binding sites for glibenclamide, a specific blocker of ATP-sensitive K+ channels , 1990, Brain Research.

[14]  M. Lazdunski,et al.  Glucose, sulfonylureas, and neurotransmitter release: role of ATP-sensitive K+ channels. , 1990, Science.

[15]  Y. Ben-Ari,et al.  Galanin and Glibenclamide Modulate the Anoxic Release of Glutamate in Rat CA3 Hippocampal Neurons , 1990, The European journal of neuroscience.

[16]  M. Lazdunski,et al.  Characterization, purification, and affinity labeling of the brain [3H]glibenclamide-binding protein, a putative neuronal ATP-regulated K+ channel. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[17]  F. Ashcroft.  Adenosine 5'-triphosphate-sensitive potassium channels. , 1988, Annual review of neuroscience.

[18]  M. Lazdunski,et al.  The receptor for antidiabetic sulfonylureas controls the activity of the ATP-modulated K+ channel in insulin-secreting cells. , 1987, The Journal of biological chemistry.

[19]  D. Hawke,et al.  The amino acid sequence of a fluorescein-labeled peptide from the active site of (Na,K)-ATPase. , 1984, The Journal of biological chemistry.

[20]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.